| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Microbial Genetics Group, Department of Biological Sciences, University of Sussex, Falmer, Brighton BN1 9QG
* Department of Medical Microbiology, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD
2Corresponding author: Dr H. McKenzie.
Received October 2, 1996
Accepted October 22, 1996
Since its discovery at the end of the nineteenth century, Moraxella (Branhamella) catarrhalis has undergone several changes of nomenclature and periodic changes in its perceived status as either a commensal or a pathogen. Molecular analysis based on DNA hybridisation or 16S rDNA sequence comparisons has established its phylogenetic position as a member of the Moraxellaceae and shown that it is related more closely to Acinetobacter spp. than to the genus Neisseria in which it was placed formerly. However, confusion with phenotypically similar Neisseria spp. can occur in the routine diagnostic laboratory if appropriate identification tests are not performed. M. catarrhalis is now accepted as the third commonest pathogen of the respiratory tract after Streptococcus pneumoniae and Haemophilus influenzae. It is a significant cause of otitis media and sinusitis in children and of lower respiratory tract infections in adults, especially those with underlying chest disease. Nosocomial spread of infection, especially within respiratory wards, has been reported. Invasive infection is uncommon, but analysis of reports for England and Wales between 1992 and 1995 revealed 89 cases of M. catarrhalis bacteraemia, with the peak incidence in children aged 1-2 years. Carriage rates of M. catarrhalis are high in children and in the elderly, but its role as a commensal organism has probably been overstated in the past. Approximately 90% of strains are now β-lactamase positive and, given that the first such strain was reported in 1976, this represents a dramatic increase in frequency over the last 20 years which has not been paralleled in any other species. The BRO-1 and BRO-2 β-lactamase enzymes of M. catarrhalis are found in other Moraxellaceae, but are not related to β-lactamases of any other species and their origin is therefore unknown. Molecular and typing studies have shown that the M. catarrhalis species is genetically heterogeneous and these methods have aided epidemiological investigation. Studies of factors that may be related to pathogenicity have shown the existence of three serotypes of lipooligosaccharide and the presence of fimbriae and a possible capsule. Some strains are serum-resistant, probably by virtue of interference with complement action, whilst transferrin- and lactoferrin-binding proteins enable the organism to obtain iron from its environment. An antibody response in humans to various M. catarrhalis antigens, including highly conserved outer-membrane proteins, has been demonstrated. Increased understanding of the organism's pathogenic properties and the host response to it may help to identify suitable vaccine targets or lead to other strategies to prevent infection. Whilst it remains, at present, the third most important respiratory pathogen, the impact of immunisation strategies for other organisms may change this position. The speed with which M. catarrhalis acquired β-lactamase demonstrates the capacity of this organism to surprise us.
This article has been cited by other articles:
|
|
 |
|
  J. M. Schwingel, K. J. Edwards, A. D. Cox, H. Masoud, J. C. Richards, F. St. Michael, C. D. Tekwe, S. Sethi, T. F. Murphy, and A. A. Campagnari Use of Moraxella catarrhalis Lipooligosaccharide Mutants To Identify Specific Oligosaccharide Epitopes Recognized by Human Serum Antibodies Infect. Immun., October 1, 2009; 77(10): 4548 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. W. de Vries, H. J. Bootsma, J. P. Hays, and P. W. M. Hermans Molecular Aspects of Moraxella catarrhalis Pathogenesis Microbiol. Mol. Biol. Rev., September 1, 2009; 73(3): 389 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bell, J. D. Turnidge, and R. N. Jones Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report J. Clin. Microbiol., July 1, 2009; 47(7): 2187 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Brooks, J. L. Sedillo, N. Wagner, C. A. Laurence, W. Wang, A. S. Attia, E. J. Hansen, and S. D. Gray-Owen Modular Arrangement of Allelic Variants Explains the Divergence in Moraxella catarrhalis UspA Protein Function Infect. Immun., November 1, 2008; 76(11): 5330 - 5340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Brooks, J. L. Sedillo, N. Wagner, W. Wang, A. S. Attia, H. Wong, C. A. Laurence, E. J. Hansen, and S. D. Gray-Owen Moraxella catarrhalis Binding to Host Cellular Receptors Is Mediated by Sequence-Specific Determinants Not Conserved among All UspA1 Protein Variants Infect. Immun., November 1, 2008; 76(11): 5322 - 5329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Schwingel, F. S. Michael, A. D Cox, H. Masoud, J. C Richards, and A. A Campagnari A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides Glycobiology, June 1, 2008; 18(6): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wirth, G. Morelli, B. Kusecek, A. van Belkum, C. van der Schee, A. Meyer, and M. Achtman The rise and spread of a new pathogen: Seroresistant Moraxella catarrhalis Genome Res., November 1, 2007; 17(11): 1647 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Plamondon, N. R. Luke, and A. A. Campagnari Identification of a Novel Two-Partner Secretion Locus in Moraxella catarrhalis Infect. Immun., June 1, 2007; 75(6): 2929 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu and X.-X. Gu Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalis Infect. Immun., May 1, 2005; 73(5): 2790 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Edwards, S. Allen, B. W. Gibson, and A. A. Campagnari Characterization of a Cluster of Three Glycosyltransferase Enzymes Essential for Moraxella catarrhalis Lipooligosaccharide Assembly J. Bacteriol., May 1, 2005; 187(9): 2939 - 2947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Luke, A. J. Howlett, J. Shao, and A. A. Campagnari Expression of Type IV Pili by Moraxella catarrhalis Is Essential for Natural Competence and Is Affected by Iron Limitation Infect. Immun., November 1, 2004; 72(11): 6262 - 6270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Luke, S. Allen, B. W. Gibson, and A. A. Campagnari Identification of a 3-Deoxy-D-manno-Octulosonic Acid Biosynthetic Operon in Moraxella catarrhalis and Analysis of a KdsA-Deficient Isogenic Mutant Infect. Immun., November 1, 2003; 71(11): 6426 - 6434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jiao, T. Hirano, Y. Hou, and X.-X. Gu Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate Vaccine Infect. Immun., November 1, 2002; 70(11): 5982 - 5989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tan and P. S. Grewal Comparison of Two Silver Staining Techniques for Detecting Lipopolysaccharides in Polyacrylamide Gels J. Clin. Microbiol., November 1, 2002; 40(11): 4372 - 4374. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tan and P. S. Grewal Endotoxin Activity of Moraxella osloensis against the Grey Garden Slug, Deroceras reticulatum Appl. Envir. Microbiol., August 1, 2002; 68(8): 3943 - 3947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Luke, R. J. Karalus, and A. A. Campagnari Inactivation of the Moraxella catarrhalis Superoxide Dismutase SodA Induces Constitutive Expression of Iron-Repressible Outer Membrane Proteins Infect. Immun., April 1, 2002; 70(4): 1889 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Schmitz, A. Beeck, M. Perdikouli, M. Boos, S. Mayer, S. Scheuring, K. Kohrer, J. Verhoef, and A. C. Fluit Production of BRO {beta}-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates J. Clin. Microbiol., April 1, 2002; 40(4): 1546 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Verduin, C. Hol, A. Fleer, H. van Dijk, and A. van Belkum Moraxella catarrhalis: from Emerging to Established Pathogen Clin. Microbiol. Rev., January 1, 2002; 15(1): 125 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tan and P. S. Grewal Pathogenicity of Moraxella osloensis, a Bacterium Associated with the Nematode Phasmarhabditis hermaphrodita, to the Slug Deroceras reticulatum Appl. Envir. Microbiol., November 1, 2001; 67(11): 5010 - 5016. [Abstract] [Full Text]
|
|
|
|
|
|
E. R. Lafontaine, N. J. Wagner, and E. J. Hansen Expression of the Moraxella catarrhalis UspA1 Protein Undergoes Phase Variation and Is Regulated at the Transcriptional Level J. Bacteriol., March 1, 2001; 183(5): 1540 - 1551. [Abstract] [Full Text]
|
|
|
|
|
|
T. F. Murphy, A. L. Brauer, N. Yuskiw, and T. J. Hiltke Antigenic Structure of Outer Membrane Protein E of Moraxella catarrhalis and Construction and Characterization of Mutants Infect. Immun., November 1, 2000; 68(11): 6250 - 6256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-G. Hu, J. Chen, J. F. Battey, and X.-X. Gu Enhancement of Clearance of Bacteria from Murine Lungs by Immunization with Detoxified Lipooligosaccharide from Moraxella catarrhalis Conjugated to Proteins Infect. Immun., September 1, 2000; 68(9): 4980 - 4985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. McClay Resistant Bacteria in the Adenoids: A Preliminary Report Arch Otolaryngol Head Neck Surg, May 1, 2000; 126(5): 625 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Luke, T. A. Russo, N. Luther, and A. A. Campagnari Use of an Isogenic Mutant Constructed in Moraxella catarrhalis To Identify a Protective Epitope of Outer Membrane Protein B1 Defined by Monoclonal Antibody 11C6 Infect. Immun., February 1, 1999; 67(2): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Myers, Y.-p. Yang, R.-p. Du, Q. Wang, R. E. Harkness, A. B. Schryvers, M. H. Klein, and S. M. Loosmore The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen Infect. Immun., September 1, 1998; 66(9): 4183 - 4192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-P. Du, Q. Wang, Y.-P. Yang, A. B. Schryvers, P. Chong, M. H. Klein, and S. M. Loosmore Cloning and Expression of the Moraxella catarrhalis Lactoferrin Receptor Genes Infect. Immun., August 1, 1998; 66(8): 3656 - 3665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Walker, R. A. Preston, J. C. Post, G. D. Ehrlich, J. H. Kalbfleisch, and K. L. Klingman Genetic Diversity among Strains of Moraxella catarrhalis: Analysis Using Multiple DNA Probes and a Single-Locus PCR-Restriction Fragment Length Polymorphism Method J. Clin. Microbiol., July 1, 1998; 36(7): 1977 - 1983. [Abstract] [Full Text]
|
|
|
|
|
|
X.-X. Gu, J. Chen, S. J. Barenkamp, J. B. Robbins, C.-M. Tsai, D. J. Lim, and J. Battey Synthesis and Characterization of Lipooligosaccharide-Based Conjugates as Vaccine Candidates for Moraxella (Branhamella) catarrhalis Infect. Immun., May 1, 1998; 66(5): 1891 - 1897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
